GlycoMScan is part of the RVO innovation mission to Switzerland

Honored and excited to be invited as a leading expert by the Netherlands Enterprise Agency to represent the Netherlands in the upcoming Innovation mission to Switzerland from 21st till 25th of April

The missions’ intent is to foster close collaborations between the Netherlands and Swiss excellent research & innovation. In this light, we want to connect with experts and explore R&D collaboration opportunities. We are dedicated to provide high quality services to enhance development of new patients therapies.

Our service offerings include pre-clinical research as:

Bio-analysis of small and large (macro) molecules
Pharmacokinetics
Characterization of novel drugs as (glycosylated) proteins, antibody-drug conjugates, (oligo)nucleotides

Please join GlycoMScan at the Swiss Biotech Day 2024 conference, wherein we will participate with a Netherlands landing spot in Room San Francisco.